[
    {
        "contents": "data\\VRX\\20170118-215505.news",
        "description": null,
        "guid": "yahoo_finance/1535801118",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/research-reports-initiated-healthcare-stocks-131500859.html",
        "pubDate": "Wed, 18 Jan 2017 13:15:00 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Research Reports Initiated on Healthcare Stocks Knight Therapeutics, Valeant Pharmaceuticals International, Merus Labs International, and Canopy Growth"
    },
    {
        "contents": "data\\VRX\\20170118-215507.news",
        "description": null,
        "guid": "yahoo_finance/3328578897",
        "link": "http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=134pe5ubv/*http://www.wsj.com/articles/allergan-admits-to-disclosure-violations-during-valeant-bid-1484693391?mod=yahoo_hs",
        "pubDate": "Tue, 17 Jan 2017 22:49:55 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "[$$] Allergan Admits to Disclosure Violations During Valeant Bid"
    },
    {
        "contents": "data\\VRX\\20170118-215507.news",
        "description": null,
        "guid": "yahoo_finance/1880057905",
        "link": "http://us.rd.yahoo.com/finance/external/xcapitalcube/rss/SIG=1404b3rg2/*http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-value-analysis-torontovrx-january-13-2017/",
        "pubDate": "Fri, 13 Jan 2017 16:14:10 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Valeant Pharmaceuticals International, Inc. \u2013 Value Analysis (TORONTO:VRX) : January 13, 2017"
    },
    {
        "contents": "data\\VRX\\20170118-215507.news",
        "description": null,
        "guid": "yahoo_finance/2225939446",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/pharma-stock-roundup-trump-targets-110211779.html",
        "pubDate": "Fri, 13 Jan 2017 11:02:11 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News"
    },
    {
        "contents": "data\\VRX\\20170118-215509.news",
        "description": null,
        "guid": "yahoo_finance/3016185222",
        "link": "http://us.rd.yahoo.com/finance/external/xinsidermonkey/rss/SIG=13cpsgp5t/*http://www.insidermonkey.com/blog/is-valeant-pharmaceuticals-intl-inc-vrx-stock-back-from-the-dead-517117/",
        "pubDate": "Thu, 12 Jan 2017 16:33:08 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Back From The Dead?"
    },
    {
        "contents": "data\\VRX\\20170118-215510.news",
        "description": null,
        "guid": "yahoo_finance/3695818182",
        "link": "http://us.rd.yahoo.com/finance/external/xcapitalcube/rss/SIG=1545h7f72/*http://www.capitalcube.com/blog/index.php/valeant-pharmaceuticals-international-inc-breached-its-50-day-moving-average-in-a-bearish-manner-vrx-ca-january-12-2017/",
        "pubDate": "Thu, 12 Jan 2017 13:11:16 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Valeant Pharmaceuticals International, Inc. breached its 50 day moving average in a Bearish Manner : VRX-CA : January 12, 2017"
    },
    {
        "contents": "data\\VRX\\20170118-215513.news",
        "description": null,
        "guid": "yahoo_finance/2710549850",
        "link": "http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13234jmnp/*http://www.fool.com/investing/2017/01/11/valeant-pharmaceuticals-separating-fact-from-ficti.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2",
        "pubDate": "Wed, 11 Jan 2017 21:54:07 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Valeant Pharmaceuticals: Separating Fact From Fiction"
    },
    {
        "contents": "data\\VRX\\20170118-215513.news",
        "description": null,
        "guid": "yahoo_finance/891544681",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/valeant-streamlines-portfolio-skincare-brands-214209103.html",
        "pubDate": "Wed, 11 Jan 2017 21:42:09 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Valeant Streamlines Portfolio with Skincare Brands Sale"
    },
    {
        "contents": "data\\VRX\\20170118-215516.news",
        "description": null,
        "guid": "yahoo_finance/2378193529",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/wednesday-top-biopharma-movers-202217751.html",
        "pubDate": "Wed, 11 Jan 2017 20:22:17 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Wednesday\u2019s Top Biopharma Movers"
    },
    {
        "contents": "data\\VRX\\20170118-215517.news",
        "description": null,
        "guid": "yahoo_finance/2545157745",
        "link": "http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12bv313fd/*https://www.thestreet.com/story/13949672/1/quot-the-new-valeant-quot.html?puc=yahoo&cm_ven=YAHOO",
        "pubDate": "Wed, 11 Jan 2017 19:51:00 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different"
    },
    {
        "contents": "data\\VRX\\20170118-215518.news",
        "description": null,
        "guid": "yahoo_finance/1552936574",
        "link": "http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=139o0kbh2/*http://blogs.barrons.com/stockstowatchtoday/2017/01/11/valeant-pharmaceuticals-now-comes-the-hard-part/?mod=yahoobarrons&ru=yahoo",
        "pubDate": "Wed, 11 Jan 2017 17:40:00 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Valeant Pharmaceuticals: Now Comes the Hard Part"
    },
    {
        "contents": "data\\VRX\\20170118-215518.news",
        "description": null,
        "guid": "yahoo_finance/303574570",
        "link": "http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=1394cjcbo/*http://blogs.barrons.com/stockstowatchtoday/2017/01/11/valeant-pharmaceuticals-a-long-road-to-recovery/?mod=yahoobarrons&ru=yahoo",
        "pubDate": "Wed, 11 Jan 2017 15:15:00 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Valeant Pharmaceuticals: 'A Long Road to Recovery'"
    },
    {
        "contents": "data\\VRX\\20170118-215519.news",
        "description": null,
        "guid": "yahoo_finance/278836297",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/options-traders-know-something-valeant-134001277.html",
        "pubDate": "Wed, 11 Jan 2017 13:40:01 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Do Options Traders Know Something About Valeant Pharmaceuticals (VRX) Stock We Don't?"
    },
    {
        "contents": "data\\VRX\\20170118-215520.news",
        "description": null,
        "guid": "yahoo_finance/3536904684",
        "link": "http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1312irk06/*http://www.fool.com/investing/2017/01/11/this-is-the-smartest-move-valeant-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2",
        "pubDate": "Wed, 11 Jan 2017 12:41:07 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time"
    },
    {
        "contents": "data\\VRX\\20170118-215521.news",
        "description": "[Reuters] - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Volkswagen AG is expected to agree to plead guilty to criminal ...",
        "guid": "yahoo_finance/3517770155",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/press-digest-wall-street-journal-052059617.html",
        "pubDate": "Wed, 11 Jan 2017 05:20:59 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "PRESS DIGEST - Wall Street Journal - Jan 11"
    },
    {
        "contents": "data\\VRX\\20170118-215522.news",
        "description": null,
        "guid": "yahoo_finance/344972899",
        "link": "http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=130qsje8b/*http://www.wsj.com/articles/loreal-looks-to-gain-u-s-share-by-buying-valeant-brands-1484053710?ru=yahoo?mod=yahoo_itp",
        "pubDate": "Wed, 11 Jan 2017 05:07:46 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "[$$] L\u2019Or\u00e9al Looks to Gain U.S. Share by Buying Valeant Brands"
    },
    {
        "contents": "data\\VRX\\20170118-215523.news",
        "description": null,
        "guid": "yahoo_finance/4098379993",
        "link": "http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ia10d1s/*http://www.wsj.com/articles/valeant-to-sell-skincare-brands-to-loreal-1484038804?ru=yahoo?mod=yahoo_itp",
        "pubDate": "Wed, 11 Jan 2017 03:53:48 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "[$$] Valeant Strikes Deals to Shed $2.1 Billion in Assets"
    },
    {
        "contents": "data\\VRX\\20170118-215523.news",
        "description": null,
        "guid": "yahoo_finance/1047712492",
        "link": "http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11iiumket/*http://www.marketwatch.com/News/Story/Story.aspx?guid=4ADF798A-D70D-11E6-B2D1-5BB37AF8AA48&siteid=yhoof2",
        "pubDate": "Tue, 10 Jan 2017 21:55:51 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "Nasdaq closes at 4th straight record\u2014marks best such streak since 1999"
    },
    {
        "contents": "data\\VRX\\20170118-215524.news",
        "description": null,
        "guid": "yahoo_finance/3519165770",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/canada-stocks-tsx-rises-financials-214933384.html",
        "pubDate": "Tue, 10 Jan 2017 21:49:33 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "CANADA STOCKS-TSX rises with financials and materials; Valeant jumps"
    },
    {
        "contents": "data\\VRX\\20170118-215525.news",
        "description": null,
        "guid": "yahoo_finance/563965098",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/canada-stocks-tsx-rises-financials-210830962.html",
        "pubDate": "Tue, 10 Jan 2017 21:08:30 GMT",
        "source": "data\\VRX\\20170118.rss",
        "title": "CANADA STOCKS-TSX rises with financials and materials groups"
    },
    {
        "contents": "data\\VRX\\20170121-090632.news",
        "description": null,
        "guid": "yahoo_finance/1761490894",
        "link": "http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13oldae8l/*https://www.thestreet.com/story/13960921/1/short-seller-andrew-left-says-trump-should-target-this-aerospace-stock.html?puc=yahoo&cm_ven=YAHOO",
        "pubDate": "Fri, 20 Jan 2017 20:31:00 GMT",
        "source": "data\\VRX\\20170121.rss",
        "title": "Short-Seller Andrew Left Says Trump Should Target This Aerospace Stock"
    },
    {
        "contents": "data\\VRX\\20170122-091140.news",
        "description": null,
        "guid": "yahoo_finance/4147366576",
        "link": "http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12vghk0gb/*http://www.fool.com/investing/2017/01/20/what-will-valeant-pharmaceuticals-sell-off-next.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2",
        "pubDate": "Sat, 21 Jan 2017 19:42:39 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "What Will Valeant Pharmaceuticals Sell Off Next?"
    },
    {
        "contents": "data\\VRX\\20170122-091141.news",
        "description": null,
        "guid": "yahoo_finance/204990475",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/loreal-buy-three-skincare-brands-074743675.html",
        "pubDate": "Tue, 10 Jan 2017 18:46:51 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant to sell assets for $2.12 billion to ease debt load"
    },
    {
        "contents": "data\\VRX\\20170122-091145.news",
        "description": null,
        "guid": "yahoo_finance/913276643",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sells-3-skincare-brands-113652771.html",
        "pubDate": "Tue, 10 Jan 2017 12:59:02 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant sells $2B in assets to begin paying down debt"
    },
    {
        "contents": "data\\VRX\\20170122-091147.news",
        "description": null,
        "guid": "yahoo_finance/1431458154",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-040309937.html",
        "pubDate": "Tue, 10 Jan 2017 04:47:04 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant to sell Dendreon unit to China's Sanpower for $820 million"
    },
    {
        "contents": "data\\VRX\\20170122-091149.news",
        "description": null,
        "guid": "yahoo_finance/1319578094",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sell-dendreon-unit-chinas-040309681.html",
        "pubDate": "Tue, 10 Jan 2017 04:03:09 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant to sell Dendreon unit to China's Sanpower for $819.9 million"
    },
    {
        "contents": "data\\VRX\\20170122-091150.news",
        "description": "[at noodls] - LAVAL, Quebec, Jan. 4, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today announced that the Board of Directors has elected Richard (Dick) U. DeSchutter ...",
        "guid": "yahoo_finance/3654041654",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=12855fpoa/*http://www.publicnow.com/view/E9685D2F9C18729A8ADFD8A7FBAEA3758C74C3F2",
        "pubDate": "Wed, 04 Jan 2017 21:33:12 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors"
    },
    {
        "contents": "data\\VRX\\20170122-091150.news",
        "description": null,
        "guid": "yahoo_finance/1444997883",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/senators-urge-action-block-drastic-203402211.html",
        "pubDate": "Wed, 21 Dec 2016 22:01:14 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Senators urge action to block drastic drug price hikes"
    },
    {
        "contents": "data\\VRX\\20170122-091155.news",
        "description": null,
        "guid": "yahoo_finance/3470303934",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/takedas-talks-acquire-valeants-salix-173642704.html",
        "pubDate": "Wed, 30 Nov 2016 17:36:42 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Takeda's talks to acquire Valeant's Salix stall - sources"
    },
    {
        "contents": "data\\VRX\\20170122-091157.news",
        "description": null,
        "guid": "yahoo_finance/4268537672",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/drugmaker-valeant-cuts-guidance-warns-162957997.html",
        "pubDate": "Tue, 08 Nov 2016 20:03:36 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant shares sink as company warns of rocky year ahead"
    },
    {
        "contents": "data\\VRX\\20170122-091200.news",
        "description": null,
        "guid": "yahoo_finance/1830503760",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/drugmaker-valeant-cuts-guidance-warns-162957325.html",
        "pubDate": "Tue, 08 Nov 2016 20:03:36 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant shares sink as company warns of rocky year ahead"
    },
    {
        "contents": "data\\VRX\\20170122-091204.news",
        "description": "[at noodls] - - Total Revenues of $2.48 billion - GAAP Cash Flow from Operations of $570 million - GAAP EPS of ($3.49) and Adjusted EPS (non-GAAP) of $1.55 - Revising 2016 Full Year Guidance LAVAL, Quebec, Nov. 8, 2016 ...",
        "guid": "yahoo_finance/857334403",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128jtvsom/*http://www.publicnow.com/view/36E4665575CA23CC2E7AA445714F00CEFE6B906F",
        "pubDate": "Tue, 08 Nov 2016 11:36:14 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Reports Third Quarter 2016 Financial Results"
    },
    {
        "contents": "data\\VRX\\20170122-091204.news",
        "description": null,
        "guid": "yahoo_finance/2049291807",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sued-ex-sprout-investors-180908308.html",
        "pubDate": "Wed, 02 Nov 2016 21:12:33 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant sued for botching marketing of female libido pill"
    },
    {
        "contents": "data\\VRX\\20170122-091206.news",
        "description": null,
        "guid": "yahoo_finance/1874026756",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/japans-takeda-shares-halted-news-001946012.html",
        "pubDate": "Wed, 02 Nov 2016 00:21:26 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Japan's Takeda shares halted on news of interest in Valeant assets"
    },
    {
        "contents": "data\\VRX\\20170122-091210.news",
        "description": null,
        "guid": "yahoo_finance/290573609",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-talks-sell-salix-stomach-202100544.html",
        "pubDate": "Tue, 01 Nov 2016 22:56:38 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant says in talks to sell Salix stomach-drug business"
    },
    {
        "contents": "data\\VRX\\20170122-091213.news",
        "description": "[at noodls] - LAVAL, Quebec, Nov. 1, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding comments attributed to anonymous ...",
        "guid": "yahoo_finance/4110588143",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128hl3kd9/*http://www.publicnow.com/view/B4F1490F51663A53D43A88FC86A61CC9BCA47EFD",
        "pubDate": "Tue, 01 Nov 2016 21:40:08 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Comments On Press Report Regarding Its Gastroenterology Business Unit"
    },
    {
        "contents": "data\\VRX\\20170122-091213.news",
        "description": "[at noodls] - LAVAL, Quebec, Oct. 31, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding comments attributed to anonymous ...",
        "guid": "yahoo_finance/2934532370",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1285bhotb/*http://www.publicnow.com/view/7624F2727F53773DA4D05F817B47123086BE4440",
        "pubDate": "Mon, 31 Oct 2016 20:53:11 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Comments On Press Report"
    },
    {
        "contents": "data\\VRX\\20170122-091213.news",
        "description": "[at noodls] - LAVAL, Quebec, Oct. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release third quarter 2016 financial results on Tuesday, ...",
        "guid": "yahoo_finance/682756898",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1280fb3om/*http://www.publicnow.com/view/741280190E9B938D3DE220A4E6DFCD060763273B",
        "pubDate": "Mon, 17 Oct 2016 16:23:06 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Announces Third Quarter Financial Results Date And Conference Call Details"
    },
    {
        "contents": "data\\VRX\\20170122-091214.news",
        "description": "[at noodls] - LAVAL, Quebec, Oct. 14, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the company's Patient Access and Pricing Committee (the 'Committee') ...",
        "guid": "yahoo_finance/4242533706",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128h8rcmr/*http://www.publicnow.com/view/6370ED49C0B3354F063CCD3A60A584C278012D62",
        "pubDate": "Fri, 14 Oct 2016 17:11:02 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Patient Access And Pricing Committee Comments On Recent Pricing Action Decisions"
    },
    {
        "contents": "data\\VRX\\20170122-091214.news",
        "description": "[at noodls] - LAVAL, Quebec, Sept. 16, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ('Valeant' or the 'Company') seeks to clarify statements made in a media report today. Pursuant ...",
        "guid": "yahoo_finance/2951821368",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128g3dtjb/*http://www.publicnow.com/view/F533724D904956CC71224CD857F06C9A3A79DF50",
        "pubDate": "Fri, 16 Sep 2016 20:38:08 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel"
    },
    {
        "contents": "data\\VRX\\20170122-091214.news",
        "description": "[at noodls] - LAVAL, Quebec, Sept. 6, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) ('Progenics') today announced ...",
        "guid": "yahoo_finance/1230006237",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=12844mtad/*http://www.publicnow.com/view/91B608427A9370F9E9D4A8BE1B515FBBF86761E2",
        "pubDate": "Tue, 06 Sep 2016 21:09:05 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor\u00ae Tablets"
    },
    {
        "contents": "data\\VRX\\20170122-091214.news",
        "description": null,
        "guid": "yahoo_finance/48930079",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/valeant-sued-over-philidor-ties-192532942.html",
        "pubDate": "Mon, 29 Aug 2016 19:39:35 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant is sued over Philidor ties, alleged racketeering"
    },
    {
        "contents": "data\\VRX\\20170122-091216.news",
        "description": null,
        "guid": "yahoo_finance/3702238115",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sued-over-philidor-ties-192532626.html",
        "pubDate": "Mon, 29 Aug 2016 19:39:35 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant is sued over Philidor ties, alleged racketeering"
    },
    {
        "contents": "data\\VRX\\20170122-091219.news",
        "description": null,
        "guid": "yahoo_finance/1287879708",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-sued-over-philidor-ties-182904100.html",
        "pubDate": "Mon, 29 Aug 2016 19:36:58 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant is sued over Philidor ties, alleged racketeering"
    },
    {
        "contents": "data\\VRX\\20170122-091220.news",
        "description": null,
        "guid": "yahoo_finance/156222253",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-hires-zoetiss-paul-herendeen-111217790.html",
        "pubDate": "Mon, 22 Aug 2016 11:12:17 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant hires Zoetis's Paul Herendeen as CFO"
    },
    {
        "contents": "data\\VRX\\20170122-091222.news",
        "description": "[at noodls] - Robert L. Rosiello to Remain at Valeant as Executive Vice President, Corporate Development and Strategy LAVAL, Quebec, Aug. 22, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ...",
        "guid": "yahoo_finance/2711949557",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128bkijlu/*http://www.publicnow.com/view/CA8FDDADEC0D083FE5244ED05B7D3A65F4186F72",
        "pubDate": "Mon, 22 Aug 2016 10:18:07 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer"
    },
    {
        "contents": "data\\VRX\\20170122-091222.news",
        "description": null,
        "guid": "yahoo_finance/3024889780",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-expected-announce-herendeen-cfo-004426829.html",
        "pubDate": "Mon, 22 Aug 2016 00:44:26 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant expected to announce Herendeen as new CFO - WSJ"
    },
    {
        "contents": "data\\VRX\\20170122-091224.news",
        "description": null,
        "guid": "yahoo_finance/1155987382",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/lpc-valeant-lenders-agree-loan-131713796.html",
        "pubDate": "Thu, 18 Aug 2016 13:17:13 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "LPC: Valeant lenders agree to loan amendment to loosen covenants"
    },
    {
        "contents": "data\\VRX\\20170122-091231.news",
        "description": "[at noodls] - LAVAL, Quebec, Aug. 18, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ('Valeant' or the 'Company') today announced that it has obtained the requisite lender approval ...",
        "guid": "yahoo_finance/385442056",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128j4tk05/*http://www.publicnow.com/view/F9A95680881CD97A07DF364826AE4804FA8B4A07",
        "pubDate": "Thu, 18 Aug 2016 12:21:09 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment"
    },
    {
        "contents": "data\\VRX\\20170122-091231.news",
        "description": null,
        "guid": "yahoo_finance/3039466630",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-stock-falls-report-criminal-130059625.html",
        "pubDate": "Thu, 11 Aug 2016 19:37:34 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant stock falls as report of criminal probe adds to woes"
    },
    {
        "contents": "data\\VRX\\20170122-091233.news",
        "description": "[at noodls] - LAVAL, Quebec, Aug. 10, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant') today issued the following statement regarding the ongoing investigation being ...",
        "guid": "yahoo_finance/2883518204",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128sqht2e/*http://www.publicnow.com/view/A5A9D62E6E14FE486936F96E198FB6528DED47B4",
        "pubDate": "Thu, 11 Aug 2016 03:01:20 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Comments On SDNY Investigation"
    },
    {
        "contents": "data\\VRX\\20170122-091233.news",
        "description": null,
        "guid": "yahoo_finance/3927211633",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/valeant-under-criminal-investigation-over-012018663.html",
        "pubDate": "Thu, 11 Aug 2016 01:20:18 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant under criminal investigation over Philidor ties - WSJ"
    },
    {
        "contents": "data\\VRX\\20170122-091237.news",
        "description": null,
        "guid": "yahoo_finance/2231775321",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/valeant-under-criminal-investigation-wsj-230653215.html",
        "pubDate": "Wed, 10 Aug 2016 23:32:37 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant under criminal investigation - WSJ"
    },
    {
        "contents": "data\\VRX\\20170122-091242.news",
        "description": null,
        "guid": "yahoo_finance/3015511416",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-under-criminal-investigation-wsj-230653606.html",
        "pubDate": "Wed, 10 Aug 2016 23:32:37 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant under criminal investigation - WSJ"
    },
    {
        "contents": "data\\VRX\\20170122-091246.news",
        "description": null,
        "guid": "yahoo_finance/3646813985",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/lpc-valeant-loans-rise-ceo-201130398.html",
        "pubDate": "Tue, 09 Aug 2016 20:11:30 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "LPC: Valeant loans rise after CEO says company to seek debt amendment"
    },
    {
        "contents": "data\\VRX\\20170122-091250.news",
        "description": "[at noodls] - 2016 Full Year Guidance Reconfirmed LAVAL, Quebec, Aug. 9, 2016 /PRNewswire/ -- Total Revenues of $2.4 billion, a decrease of 11% versus the second quarter of 2015 GAAP EPS ($0.88) and Adjusted EPS (non-GAAP) ...",
        "guid": "yahoo_finance/628671418",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1286o36fa/*http://www.publicnow.com/view/220D7A4E104294546F66D6981108546BFE140148",
        "pubDate": "Tue, 09 Aug 2016 10:10:08 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results"
    },
    {
        "contents": "data\\VRX\\20170122-091250.news",
        "description": "[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced the relaunch of its generic ofloxacin otic solution to treat bacterial ear ...",
        "guid": "yahoo_finance/1995700050",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128b3bc12/*http://www.publicnow.com/view/3E2B92B2573830CCB56B85E274AFEF6F1EA4A7F7",
        "pubDate": "Mon, 08 Aug 2016 21:10:16 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Announces Relaunch Of Generic Ofloxacin Otic Solution"
    },
    {
        "contents": "data\\VRX\\20170122-091251.news",
        "description": "[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced its commitment to improving the lives of Wilson disease patients around ...",
        "guid": "yahoo_finance/3729847845",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=12887g0io/*http://www.publicnow.com/view/F8F1EDC41C15A84BC4A4E7E085E78BDEBB97C894",
        "pubDate": "Mon, 08 Aug 2016 21:10:16 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Announces Significant Support For Education And Research Regarding Wilson Disease"
    },
    {
        "contents": "data\\VRX\\20170122-091251.news",
        "description": "[at noodls] - LAVAL, Quebec, Aug. 8, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant' or the 'Company') today announced that it has entered into a licensing agreement ...",
        "guid": "yahoo_finance/711012682",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128he9i0b/*http://www.publicnow.com/view/0FB0D110D34FF0B5041B22D25EC8775160289A8A",
        "pubDate": "Mon, 08 Aug 2016 12:18:05 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Announces Licensing Agreement With Norgine B.V. For NER1006 In U.S. And Canada"
    },
    {
        "contents": "data\\VRX\\20170122-091251.news",
        "description": "[at noodls] - Christina Ackermann Named Executive Vice President and General Counsel Scott Hirsch Joins Valeant as Senior Vice President, Business Strategy and Communications Senior Leaders Take on Expanded Roles; Executive ...",
        "guid": "yahoo_finance/1017003063",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128vm9ptp/*http://www.publicnow.com/view/8CAEED134A161936DAA5F9DEB6CF51A686E3C611",
        "pubDate": "Mon, 08 Aug 2016 12:18:05 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Announces Changes To Executive Management Team"
    },
    {
        "contents": "data\\VRX\\20170122-091251.news",
        "description": "[at noodls] - LAVAL, Quebec, July 28, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve ...",
        "guid": "yahoo_finance/1878356206",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1286qm085/*http://www.publicnow.com/view/2A3F975B6C9B30C3306DF81DD1CC80A186F1F511",
        "pubDate": "Thu, 28 Jul 2016 21:28:04 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors"
    },
    {
        "contents": "data\\VRX\\20170122-091251.news",
        "description": null,
        "guid": "yahoo_finance/546665029",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/u-fda-panel-backs-valeant-194117169.html",
        "pubDate": "Tue, 19 Jul 2016 20:22:17 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "U.S. FDA panel backs Valeant psoriasis drug with risk program"
    },
    {
        "contents": "data\\VRX\\20170122-091253.news",
        "description": null,
        "guid": "yahoo_finance/3596236539",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/u-fda-panel-backs-valeant-192541935.html",
        "pubDate": "Tue, 19 Jul 2016 19:25:41 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "U.S. FDA panel backs Valeant psoriasis drug with risk management"
    },
    {
        "contents": "data\\VRX\\20170122-091255.news",
        "description": null,
        "guid": "yahoo_finance/1788370195",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/bad-wall-streets-golden-boy-031523835.html",
        "pubDate": "Sun, 17 Jul 2016 03:15:23 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Bad year for Wall Street's Golden Boy Ackman"
    },
    {
        "contents": "data\\VRX\\20170122-091257.news",
        "description": null,
        "guid": "yahoo_finance/330995388",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/bad-wall-streets-golden-boy-021724403.html",
        "pubDate": "Sun, 17 Jul 2016 02:17:24 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Bad year for Wall Street's Golden Boy Ackman"
    },
    {
        "contents": "data\\VRX\\20170122-091259.news",
        "description": "[AFP] - For a Wall Street star once dubbed the \"Baby Buffett,\" Bill Ackman is having a pretty bad year. Huge bets on companies like Valeant and Herbalife have delivered steep losses to the flamboyant billionaire's Pershing Square hedge fund. With some $12 billion under management, Pershing lost around 20 percent in the first half this year, securities filings show.",
        "guid": "yahoo_finance/3507043852",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://au.finance.yahoo.com/news/bad-wall-streets-golden-boy-171523532.html",
        "pubDate": "Sat, 16 Jul 2016 17:15:23 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Bad year for Wall Street's Golden Boy Ackman"
    },
    {
        "contents": "data\\VRX\\20170122-091303.news",
        "description": null,
        "guid": "yahoo_finance/1898724493",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-psoriasis-drugs-suicide-risk-125928188.html",
        "pubDate": "Fri, 15 Jul 2016 13:30:59 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant psoriasis drug's suicide risk hard to assess -FDA Staff"
    },
    {
        "contents": "data\\VRX\\20170122-091305.news",
        "description": "[at noodls] - LAVAL, Quebec, July 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on August 9, 2016 ...",
        "guid": "yahoo_finance/2617432131",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128hd0sm7/*http://www.publicnow.com/view/B07EB068DD46FE3EBDA1BCE61764CFA9143C9D80",
        "pubDate": "Fri, 15 Jul 2016 12:28:05 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details"
    },
    {
        "contents": "data\\VRX\\20170122-091305.news",
        "description": null,
        "guid": "yahoo_finance/2406336331",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-psoriasis-drug-safety-challenging-122601422.html",
        "pubDate": "Fri, 15 Jul 2016 12:26:01 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant psoriasis drug safety challenging to assess -FDA Staff"
    },
    {
        "contents": "data\\VRX\\20170122-091307.news",
        "description": "[at noodls] - LAVAL, Quebec, July 14, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ('Valeant' or the 'Company') today commented on recent stock transactions made by Valeant's ...",
        "guid": "yahoo_finance/2044174105",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128pdbg8t/*http://www.publicnow.com/view/A1E981997F5F5F90CD074FA524F820C5C5D08096",
        "pubDate": "Thu, 14 Jul 2016 13:28:07 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant Pharmaceuticals Comments On Recent Stock Transactions"
    },
    {
        "contents": "data\\VRX\\20170122-091307.news",
        "description": null,
        "guid": "yahoo_finance/1468068438",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/lpc-valeant-chips-away-us-174142508.html",
        "pubDate": "Fri, 10 Jun 2016 17:41:42 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "LPC: Valeant chips away at US$31bn debt burden with US$47.5m repayment"
    },
    {
        "contents": "data\\VRX\\20170122-091309.news",
        "description": null,
        "guid": "yahoo_finance/1905373350",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-shares-plunge-slashes-profit-144515239.html",
        "pubDate": "Tue, 07 Jun 2016 14:45:15 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant shares plunge after it slashes profit forecast"
    },
    {
        "contents": "data\\VRX\\20170122-091311.news",
        "description": null,
        "guid": "yahoo_finance/2985257833",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-rejected-joint-takeover-bid-033148516.html",
        "pubDate": "Fri, 27 May 2016 03:31:48 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant rejected joint takeover bid from Takeda, TPG in spring - source"
    },
    {
        "contents": "data\\VRX\\20170122-091313.news",
        "description": null,
        "guid": "yahoo_finance/3561268667",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/valeant-appoints-tycos-sam-eldessouky-112139669.html",
        "pubDate": "Thu, 26 May 2016 15:52:33 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant appoints Tyco's Sam Eldessouky corporate controller"
    },
    {
        "contents": "data\\VRX\\20170122-091318.news",
        "description": null,
        "guid": "yahoo_finance/2811427456",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/warren-buffett-says-more-likely-145701817.html",
        "pubDate": "Mon, 02 May 2016 19:27:59 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Warren Buffett says more likely to buy IBM shares than sell - CNBC"
    },
    {
        "contents": "data\\VRX\\20170122-091319.news",
        "description": null,
        "guid": "yahoo_finance/100579448",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-files-overdue-financials-averts-183335090.html",
        "pubDate": "Fri, 29 Apr 2016 18:33:35 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant files overdue financials, averts debt default"
    },
    {
        "contents": "data\\VRX\\20170122-091321.news",
        "description": null,
        "guid": "yahoo_finance/1267957266",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/us-stocks-wall-st-ends-205406240.html",
        "pubDate": "Mon, 21 Mar 2016 20:54:06 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "US STOCKS-Wall St ends flat as recent rally spurs caution"
    },
    {
        "contents": "data\\VRX\\20170122-091323.news",
        "description": null,
        "guid": "yahoo_finance/416905114",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-ceo-pearson-exit-ackman-204253671.html",
        "pubDate": "Mon, 21 Mar 2016 20:42:53 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant CEO Pearson to exit, Ackman to join board"
    },
    {
        "contents": "data\\VRX\\20170122-091324.news",
        "description": null,
        "guid": "yahoo_finance/3776377949",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/us-stocks-wall-st-flat-190607844.html",
        "pubDate": "Mon, 21 Mar 2016 19:06:07 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "US STOCKS-Wall St flat as Fed still dominates investor sentiment"
    },
    {
        "contents": "data\\VRX\\20170122-091326.news",
        "description": null,
        "guid": "yahoo_finance/1169219789",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/p-says-may-cut-ackman-211214242.html",
        "pubDate": "Thu, 17 Mar 2016 21:12:14 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "S&P says it may cut Ackman hedge fund's rating"
    },
    {
        "contents": "data\\VRX\\20170122-091328.news",
        "description": null,
        "guid": "yahoo_finance/1853144164",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/us-stocks-wall-st-dips-203038623.html",
        "pubDate": "Tue, 15 Mar 2016 20:30:38 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "US STOCKS-Wall St dips as healthcare lags before Fed statement"
    },
    {
        "contents": "data\\VRX\\20170122-091330.news",
        "description": null,
        "guid": "yahoo_finance/75391181",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-shares-plunge-49-default-191835944.html",
        "pubDate": "Tue, 15 Mar 2016 19:18:35 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant shares plunge 49% on default warning, outlook"
    },
    {
        "contents": "data\\VRX\\20170122-091334.news",
        "description": null,
        "guid": "yahoo_finance/1410279160",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/us-stocks-health-materials-shares-191410321.html",
        "pubDate": "Tue, 15 Mar 2016 19:14:10 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "US STOCKS-Health, materials shares drag on Wall St in lull before Fed news"
    },
    {
        "contents": "data\\VRX\\20170122-091336.news",
        "description": null,
        "guid": "yahoo_finance/835443339",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-shares-plunge-45-revised-165532986.html",
        "pubDate": "Tue, 15 Mar 2016 16:55:32 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant shares plunge 45% on revised forecasts"
    },
    {
        "contents": "data\\VRX\\20170122-091337.news",
        "description": null,
        "guid": "yahoo_finance/3861502502",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/us-stocks-p-500-ticks-215247260.html",
        "pubDate": "Mon, 07 Mar 2016 21:52:47 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "US STOCKS-S&P 500 ticks above 2,000 as energy offsets tech slide"
    },
    {
        "contents": "data\\VRX\\20170122-091339.news",
        "description": null,
        "guid": "yahoo_finance/4023842742",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/us-stocks-p-500-flat-203847217.html",
        "pubDate": "Mon, 07 Mar 2016 20:38:47 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "US STOCKS-S&P 500 flat as energy spike offsets tech slide"
    },
    {
        "contents": "data\\VRX\\20170122-091341.news",
        "description": null,
        "guid": "yahoo_finance/2939324190",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/valeant-shares-slide-news-probe-005438647.html",
        "pubDate": "Tue, 01 Mar 2016 00:54:38 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant shares slide on news of probe by U.S. SEC"
    },
    {
        "contents": "data\\VRX\\20170122-091343.news",
        "description": null,
        "guid": "yahoo_finance/1751770184",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/us-stocks-p-500-falls-203144340.html",
        "pubDate": "Mon, 29 Feb 2016 20:31:44 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "US STOCKS-S&P 500 falls below closely watched threshold"
    },
    {
        "contents": "data\\VRX\\20170122-091344.news",
        "description": null,
        "guid": "yahoo_finance/136920545",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://uk.finance.yahoo.com/news/valeant-may-restate-revenues-wsj-234233503.html",
        "pubDate": "Mon, 22 Feb 2016 23:42:33 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Valeant may have to restate revenues: WSJ"
    },
    {
        "contents": "data\\VRX\\20170122-091346.news",
        "description": null,
        "guid": "yahoo_finance/59612231",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/exclusive-valeant-considers-selling-contact-010127434.html",
        "pubDate": "Tue, 08 Dec 2015 01:01:27 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Exclusive: Valeant considers selling contact lens maker Paragon - sources"
    },
    {
        "contents": "data\\VRX\\20170122-091348.news",
        "description": null,
        "guid": "yahoo_finance/3116310129",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/ackman-raises-stake-valeant-pharma-224507717.html",
        "pubDate": "Mon, 23 Nov 2015 23:45:00 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Ackman boosts stake in drugmaker Valeant"
    },
    {
        "contents": "data\\VRX\\20170122-091350.news",
        "description": null,
        "guid": "yahoo_finance/1764775116",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://in.finance.yahoo.com/news/exclusive-valueact-gains-wiped-valeant-224833764.html",
        "pubDate": "Mon, 23 Nov 2015 23:39:19 GMT",
        "source": "data\\VRX\\20170122.rss",
        "title": "Exclusive - ValueAct gains for the year wiped out by Valeant loss"
    },
    {
        "contents": "data\\VRX\\20170124-090428.news",
        "description": null,
        "guid": "yahoo_finance/2584452764",
        "link": "http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=132thmf0q/*https://www.thestreet.com/story/13962492/1/analysts-dismiss-citron-s-sour-take-on-transdigm.html?puc=yahoo&cm_ven=YAHOO",
        "pubDate": "Mon, 23 Jan 2017 19:45:00 GMT",
        "source": "data\\VRX\\20170124.rss",
        "title": "Analysts dismiss Citron's sour take on TransDigm"
    },
    {
        "contents": "data\\VRX\\20170126-091148.news",
        "description": null,
        "guid": "yahoo_finance/395233618",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/bear-day-valeant-pharmaceuticals-vrx-120012015.html",
        "pubDate": "Thu, 26 Jan 2017 12:00:12 GMT",
        "source": "data\\VRX\\20170126.rss",
        "title": "Bear of the Day: Valeant Pharmaceuticals (VRX)"
    }
]